BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 16447778)

  • 1. [Regulation of the protein degradation pathway by the ubiquitin family: its implication in neurodegenerative diseases].
    Chiba T; Tanaka K
    Rinsho Shinkeigaku; 2005 Nov; 45(11):976-8. PubMed ID: 16447778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does impairment of the ubiquitin-proteasome system or the autophagy-lysosome pathway predispose individuals to neurodegenerative disorders such as Parkinson's disease?
    Matsuda N; Tanaka K
    J Alzheimers Dis; 2010; 19(1):1-9. PubMed ID: 20061621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formation of distinct inclusion bodies by inhibition of ubiquitin-proteasome and autophagy-lysosome pathways.
    Lee J; Yang KH; Joe CO; Kang SS
    Biochem Biophys Res Commun; 2011 Jan; 404(2):672-7. PubMed ID: 21147067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ubiquitin-proteasome pathway in Parkinson's disease and other neurodegenerative diseases.
    Ross CA; Pickart CM
    Trends Cell Biol; 2004 Dec; 14(12):703-11. PubMed ID: 15564047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parkin-mediated lysine 63-linked polyubiquitination: a link to protein inclusions formation in Parkinson's and other conformational diseases?
    Lim KL; Dawson VL; Dawson TM
    Neurobiol Aging; 2006 Apr; 27(4):524-9. PubMed ID: 16213628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ubiquitin-proteasome system and Parkinson's diseases.
    Betarbet R; Sherer TB; Greenamyre JT
    Exp Neurol; 2005 Feb; 191 Suppl 1():S17-27. PubMed ID: 15629758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parkin promotes proteasomal degradation of p62: implication of selective vulnerability of neuronal cells in the pathogenesis of Parkinson's disease.
    Song P; Li S; Wu H; Gao R; Rao G; Wang D; Chen Z; Ma B; Wang H; Sui N; Deng H; Zhang Z; Tang T; Tan Z; Han Z; Lu T; Zhu Y; Chen Q
    Protein Cell; 2016 Feb; 7(2):114-29. PubMed ID: 26746706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of ubiquitin proteasome system: risk for neurodegenerative diseases.
    Zheng C; Geetha T; Babu JR
    Neurodegener Dis; 2014; 14(4):161-75. PubMed ID: 25413678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aggregopathy in neurodegenerative diseases: mechanisms and therapeutic implication.
    Dohm CP; Kermer P; Bähr M
    Neurodegener Dis; 2008; 5(6):321-38. PubMed ID: 18309232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Life and death in the trash heap: The ubiquitin proteasome pathway and UCHL1 in brain aging, neurodegenerative disease and cerebral Ischemia.
    Graham SH; Liu H
    Ageing Res Rev; 2017 Mar; 34():30-38. PubMed ID: 27702698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein aggregation and the ubiquitin proteasome pathway: gaining the UPPer hand on neurodegeneration.
    Berke SJ; Paulson HL
    Curr Opin Genet Dev; 2003 Jun; 13(3):253-61. PubMed ID: 12787787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aging and regulated protein degradation: who has the UPPer hand?
    Vernace VA; Schmidt-Glenewinkel T; Figueiredo-Pereira ME
    Aging Cell; 2007 Oct; 6(5):599-606. PubMed ID: 17681036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of mitophagy by the ubiquitin pathway in neurodegenerative diseases.
    Desai S; Juncker M; Kim C
    Exp Biol Med (Maywood); 2018 Mar; 243(6):554-562. PubMed ID: 29316798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of ubiquitin-proteasome-mediated proteolysis in nervous system disease.
    Hegde AN; Upadhya SC
    Biochim Biophys Acta; 2011 Feb; 1809(2):128-40. PubMed ID: 20674814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The triage of damaged proteins: degradation by the ubiquitin-proteasome pathway or repair by molecular chaperones.
    Marques C; Guo W; Pereira P; Taylor A; Patterson C; Evans PC; Shang F
    FASEB J; 2006 Apr; 20(6):741-3. PubMed ID: 16469848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ubiquitin signaling in neurodegenerative diseases: an autophagy and proteasome perspective.
    Le Guerroué F; Youle RJ
    Cell Death Differ; 2021 Feb; 28(2):439-454. PubMed ID: 33208890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twenty years since the discovery of the parkin gene.
    Hattori N; Mizuno Y
    J Neural Transm (Vienna); 2017 Sep; 124(9):1037-1054. PubMed ID: 28620835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the ubiquitin-proteasomal pathway in Parkinson's disease and other neurodegenerative disorders.
    Chung KK; Dawson VL; Dawson TM
    Trends Neurosci; 2001 Nov; 24(11 Suppl):S7-14. PubMed ID: 11881748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein damage, repair and proteolysis.
    Chondrogianni N; Petropoulos I; Grimm S; Georgila K; Catalgol B; Friguet B; Grune T; Gonos ES
    Mol Aspects Med; 2014 Feb; 35():1-71. PubMed ID: 23107776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ubiquitin proteasome system as a pharmacological target in neurodegeneration.
    Hol EM; Fischer DF; Ovaa H; Scheper W
    Expert Rev Neurother; 2006 Sep; 6(9):1337-47. PubMed ID: 17009921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.